Clinical study of nephron-sparing surgery for renal cell carcinoma

Yoshinori Shirasaki, Tomoyasu Tsushima, Yasutomo Nasu, Hiromi Kumon, Takaharu Ichikawa, Kenji Aramaki, Seiichi Itoh, Naoki Mitsuhata, Ryuji Fujita, Mitsuo Nishi, Miyabi Inoue, Toshihide Hayashi, Ayano Ishii, Hitoshi Takamoto

Research output: Contribution to journalArticle

Abstract

From January 1995 to June 2001, we performed nephron-sparing surgery (NSS) on 47 patients with renal cell carcinoma. The indication was imperative for 10 patients, but elective for 37 patients. Moreover, we performed renal scintigraphy for the quantitative measurement of postoperative residual renal function in 14 elective cases. Most of the patients were operated on uneventfully, although we experienced postoperative hematoma and urinoma among the elective cases. There were two local recurrences among the imperative cases at median follw-up of 780 days and one incidence of regional lymph node metastasis among the elective cases at median follow-up of 724 days. Postoperative renal scintigraphy showed well-preserved renal function of the operated kidney in all except for 2 cases. The acceptable oncological and functional outcomes support the validity of NSS for treating small renal cell carcinoma in patients with a normal contralateral kidney.

Original languageEnglish
Pages (from-to)242-247
Number of pages6
JournalNishinihon Journal of Urology
Volume65
Issue number5
Publication statusPublished - 2003

Fingerprint

Nephrons
Renal Cell Carcinoma
Kidney
Radionuclide Imaging
Urinoma
Small Cell Carcinoma
Hematoma
Clinical Studies
Lymph Nodes
Neoplasm Metastasis
Recurrence
Incidence

Keywords

  • Nephron-sparing surgery
  • Renal cell carcinoma
  • Renal function

ASJC Scopus subject areas

  • Urology

Cite this

Shirasaki, Y., Tsushima, T., Nasu, Y., Kumon, H., Ichikawa, T., Aramaki, K., ... Takamoto, H. (2003). Clinical study of nephron-sparing surgery for renal cell carcinoma. Nishinihon Journal of Urology, 65(5), 242-247.

Clinical study of nephron-sparing surgery for renal cell carcinoma. / Shirasaki, Yoshinori; Tsushima, Tomoyasu; Nasu, Yasutomo; Kumon, Hiromi; Ichikawa, Takaharu; Aramaki, Kenji; Itoh, Seiichi; Mitsuhata, Naoki; Fujita, Ryuji; Nishi, Mitsuo; Inoue, Miyabi; Hayashi, Toshihide; Ishii, Ayano; Takamoto, Hitoshi.

In: Nishinihon Journal of Urology, Vol. 65, No. 5, 2003, p. 242-247.

Research output: Contribution to journalArticle

Shirasaki, Y, Tsushima, T, Nasu, Y, Kumon, H, Ichikawa, T, Aramaki, K, Itoh, S, Mitsuhata, N, Fujita, R, Nishi, M, Inoue, M, Hayashi, T, Ishii, A & Takamoto, H 2003, 'Clinical study of nephron-sparing surgery for renal cell carcinoma', Nishinihon Journal of Urology, vol. 65, no. 5, pp. 242-247.
Shirasaki Y, Tsushima T, Nasu Y, Kumon H, Ichikawa T, Aramaki K et al. Clinical study of nephron-sparing surgery for renal cell carcinoma. Nishinihon Journal of Urology. 2003;65(5):242-247.
Shirasaki, Yoshinori ; Tsushima, Tomoyasu ; Nasu, Yasutomo ; Kumon, Hiromi ; Ichikawa, Takaharu ; Aramaki, Kenji ; Itoh, Seiichi ; Mitsuhata, Naoki ; Fujita, Ryuji ; Nishi, Mitsuo ; Inoue, Miyabi ; Hayashi, Toshihide ; Ishii, Ayano ; Takamoto, Hitoshi. / Clinical study of nephron-sparing surgery for renal cell carcinoma. In: Nishinihon Journal of Urology. 2003 ; Vol. 65, No. 5. pp. 242-247.
@article{021804a7a7c1467dadb452a1a81b3f82,
title = "Clinical study of nephron-sparing surgery for renal cell carcinoma",
abstract = "From January 1995 to June 2001, we performed nephron-sparing surgery (NSS) on 47 patients with renal cell carcinoma. The indication was imperative for 10 patients, but elective for 37 patients. Moreover, we performed renal scintigraphy for the quantitative measurement of postoperative residual renal function in 14 elective cases. Most of the patients were operated on uneventfully, although we experienced postoperative hematoma and urinoma among the elective cases. There were two local recurrences among the imperative cases at median follw-up of 780 days and one incidence of regional lymph node metastasis among the elective cases at median follow-up of 724 days. Postoperative renal scintigraphy showed well-preserved renal function of the operated kidney in all except for 2 cases. The acceptable oncological and functional outcomes support the validity of NSS for treating small renal cell carcinoma in patients with a normal contralateral kidney.",
keywords = "Nephron-sparing surgery, Renal cell carcinoma, Renal function",
author = "Yoshinori Shirasaki and Tomoyasu Tsushima and Yasutomo Nasu and Hiromi Kumon and Takaharu Ichikawa and Kenji Aramaki and Seiichi Itoh and Naoki Mitsuhata and Ryuji Fujita and Mitsuo Nishi and Miyabi Inoue and Toshihide Hayashi and Ayano Ishii and Hitoshi Takamoto",
year = "2003",
language = "English",
volume = "65",
pages = "242--247",
journal = "Nishinihon Journal of Urology",
issn = "0029-0726",
publisher = "Kyushu University, Faculty of Science",
number = "5",

}

TY - JOUR

T1 - Clinical study of nephron-sparing surgery for renal cell carcinoma

AU - Shirasaki, Yoshinori

AU - Tsushima, Tomoyasu

AU - Nasu, Yasutomo

AU - Kumon, Hiromi

AU - Ichikawa, Takaharu

AU - Aramaki, Kenji

AU - Itoh, Seiichi

AU - Mitsuhata, Naoki

AU - Fujita, Ryuji

AU - Nishi, Mitsuo

AU - Inoue, Miyabi

AU - Hayashi, Toshihide

AU - Ishii, Ayano

AU - Takamoto, Hitoshi

PY - 2003

Y1 - 2003

N2 - From January 1995 to June 2001, we performed nephron-sparing surgery (NSS) on 47 patients with renal cell carcinoma. The indication was imperative for 10 patients, but elective for 37 patients. Moreover, we performed renal scintigraphy for the quantitative measurement of postoperative residual renal function in 14 elective cases. Most of the patients were operated on uneventfully, although we experienced postoperative hematoma and urinoma among the elective cases. There were two local recurrences among the imperative cases at median follw-up of 780 days and one incidence of regional lymph node metastasis among the elective cases at median follow-up of 724 days. Postoperative renal scintigraphy showed well-preserved renal function of the operated kidney in all except for 2 cases. The acceptable oncological and functional outcomes support the validity of NSS for treating small renal cell carcinoma in patients with a normal contralateral kidney.

AB - From January 1995 to June 2001, we performed nephron-sparing surgery (NSS) on 47 patients with renal cell carcinoma. The indication was imperative for 10 patients, but elective for 37 patients. Moreover, we performed renal scintigraphy for the quantitative measurement of postoperative residual renal function in 14 elective cases. Most of the patients were operated on uneventfully, although we experienced postoperative hematoma and urinoma among the elective cases. There were two local recurrences among the imperative cases at median follw-up of 780 days and one incidence of regional lymph node metastasis among the elective cases at median follow-up of 724 days. Postoperative renal scintigraphy showed well-preserved renal function of the operated kidney in all except for 2 cases. The acceptable oncological and functional outcomes support the validity of NSS for treating small renal cell carcinoma in patients with a normal contralateral kidney.

KW - Nephron-sparing surgery

KW - Renal cell carcinoma

KW - Renal function

UR - http://www.scopus.com/inward/record.url?scp=0037983774&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0037983774&partnerID=8YFLogxK

M3 - Article

AN - SCOPUS:0037983774

VL - 65

SP - 242

EP - 247

JO - Nishinihon Journal of Urology

JF - Nishinihon Journal of Urology

SN - 0029-0726

IS - 5

ER -